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MAJOR CHANGES IN 2020 POST-CARDIAC ARREST CARE 
GUIDELINE
The 2020 Korean Post-cardiac Arrest Care Guidelines are medical recommendations derived 
based on scientific evidence for post-cardiac arrest care. These guidelines are based on the 2020 
scientific consensus and treatment recommendations of the International Liaison Committee on 
Resuscitation and we additionally considered the research papers in the post-cardiac arrest care 
field which were published after the International Liaison Committee on Resuscitation review.1,2 
In these guidelines, topics which are clinically important and needed further consideration were 
reviewed in the form of adaptation or hybridization. Meta-analyses or scoping reviews for addi-
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tional PICOs (Population, Intervention, Control, Outcomes) were 
also performed.
 The level of evidence (LOE) used the definition of the American 
Heart Association. It was divided into level A, the highest level, to 
level C, the lowest level.3 Details are as follows. Level A is a LOE 
based on one or more high-quality randomized controlled stud-
ies, a meta-analysis of results of high-quality randomized con-
trolled trials (RCTs), or one or more randomized controlled studies 
from a high-quality registry. Level B-R (randomized) is a LOE based 
on one or more moderate quality randomized controlled studies 
or a meta-analysis of results of randomized controlled studies 
with moderate quality. Level B-NR (non-randomized) is a LOE 
based on one or more well-performed non-randomized observa-
tional studies or moderate quality evidence from a well-per-
formed registry, well-performed randomized observational stud-
ies, or meta-analysis results from registry studies. Level C-LD 
(limited data) is a LOE based on a RCT or a non-random observa-
tional study. This level is based on results of studies with limita-
tions in study design and implementation, randomized controlled 
studies, non-random observational studies, or meta-analysis re-
sults of studies with limitations in study design and implementa-
tion as registry studies, or physiological or mechanical studies in 
human. Level C-EO (expert opinion) is based on consensus opin-
ion of experts. 
 The recommendation grade was judged on the basis of direc-
tion (benefit and harm) and strength (strong recommendation 
and weak recommendation) based on the recommendation in the 
GRADE (Grading of Recommendations Assessment, Development 
and Evaluation) method. Classification is divided into three cate-
gories used by the American Heart Association.3,4 Class I is when 
the benefit of the care or intervention is very high relative to the 
risk (it is appropriate for most physicians to provide care or inter-
vention to most patients). Class IIa is when a care or intervention 
is generally useful (with some important exceptions, it is appro-
priate for most physicians to provide care or intervention). Class 
IIb is when a care or intervention has a positive effect, although 
the evidence is not clear. Class III (no benefit) is when care or in-
tervention is ineffective (it is the case when high-level studies 
have not demonstrated efficacy). Class III (harm) is when a care 
or intervention has a higher risk than benefits (in case of harm).
 Compared to the 2015 guidelines, changes made in the 2020 
guidelines are as follows.
 
Airway and breathing
We recommend avoiding hypoxemia in adults who have a return 
of spontaneous circulation (ROSC) after a cardiac arrest (Class I, 
Level C-LD).
 We suggest to apply 100% oxygen until oxygen saturation 
(SpO2) or partial pressure of oxygen in the arterial blood (PaO2) 
can be accurately measured (Class IIa, Level C-LD) in adults who 
have ROSC after a cardiac arrest. In addition, we suggest avoiding 
hyperoxemia by titrating the fraction of inspired oxygen to target 
an oxygen saturation of 92% to 98% in patients who remain co-
matose after ROSC (Class IIb, Level B-R). 
 We suggest maintaining a partial pressure of carbon dioxide in 
the arterial blood (PaCO2) within a normal physiological range of 
35 to 45 mmHg in adults who have ROSC after a cardiac arrest 
(Class IIb, Level C-LD).
Intervention for acute coronary syndrome
We suggest performing coronary angiography after neurological 
recovery from hospitalization rather than early coronary angiog-
raphy for adults without ST segment elevation on electrocardiog-
raphy (ECG) after ROSC when no obvious non-cardiac cause is 
identified (Class IIb, Level B-NR).
 We suggest performing early coronary angiography in the case 
of electrical instability with persistent ventricular tachycardia or 
ventricular fibrillation, or cardiogenic shock even if there is no ST 
segment elevation on the ECG after ROSC (Class IIa, Level B-NR).
Temperature control
We recommend performing targeted temperature management 
(TTM) to all adult cardiac arrest patients who do not respond to 
verbal commands after ROSC regardless of the initial ECG rhythm 
(Class I, Level B-R).
 A target temperature of 32°C to 36°C is recommended for adult 
patients who do not follow commands after ROSC (Class I, Level 
BR). It is reasonable to maintain TTM for at least 24 hours after 
achieving target temperature (Class IIa, Level B-NR).
 We do not recommend the routine use of rapid infusion of cold 
fluids intravenously to induce hypothermia after ROSC in a pre-
hospital setting (Class III, Level A).
Control of seizures
We recommend treatment of clinically apparent seizures in co-
matose adults after ROSC (Class I, Level C-LD). Anticonvulsants 
that are commonly used for the treatment of seizures caused by 
other etiologies may be considered for the patients with seizures 
after ROSC (Class IIb, Level C-LD).
 We suggest that routine seizure prophylaxis is not used in co-
matose adults after ROSC (Class III, Level B-NR).
Use of prophylactic antibiotics
The benefit of the routine use of prophylactic antibiotics in pa-
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tients with ROSC is uncertain (Class IIb, Level B-R).
Neuroprognostication in comatose adult patients 
treated with TTM after ROSC
The neurological prognostication in an adult comatose patient 
after ROSC should not be performed by only one test result. It 
should use a multimodal approach using the results of various 
tests such as clinical examination, electrophysiology, biomarkers, 
and imaging (Class I, Level B-NR). Even though the individual test 
is performed earlier, we suggest using the multimodal approach 
at a minimum of 72 hours after normothermia (5 days after ROSC) 
(Class IIa, Level B-NR).
 Bilateral absent pupillary light reflexes or corneal reflexes, quan-
titative pupillometry in patients who remain comatose at 72 hours 
or later after ROSC may predict a poor neurological outcome in 
combination with other prognostic tests (Class IIb, Level C-LD).
 The presence of myoclonus and status myoclonus within 72 
hours of ROSC may predict a poor neurological outcome in com-
bination with other prognostic tests (Class IIb, Level B-NR). We 
suggest electroencephalography (EEG) recording in case of status 
myoclonus to find related epileptic activity (Class IIb, Level C-LD).
 Bilateral absent N20 waves on somatosensory evoked potential 
(SSEP) more than 24 hours after ROSC may predict a poor neuro-
logical outcome in combination with other prognostic tests (Class 
IIb, Level B-NR).
 The presence of unequivocal seizures on EEG during the 72 
hours after ROSC may predict a poor neurological outcome in 
combination with other prognostic tests (Class IIb, Level B-NR).
 Burst suppression on EEG after sedation has cleared at 72 hours 
or more after ROSC may predict a poor neurological outcome in 
combination with other prognostic tests (Class IIb, Level B-NR).
 The absence of a normal trace within 36 hours after ROSC in 
amplitude-integrated EEG monitoring may predict a poor neuro-
logical outcome in combination with other prognostic tests (Class 
IIb, Level B-NR).
 High serum levels of neuron specific enolase (NSE) measured 
at 24-72 hours after ROSC may predict a poor neurological out-
come in combination with other prognostic tests (Class IIb, Level 
B-NR).
 Reduced gray-white matter ratio (GWR) on brain computed 
tomography (CT) within 24 hours after ROSC, or extensive areas 
of restricted diffusion and reduced apparent diffusion coefficient 
(ADC) on magnetic resonance imaging (MRI) at 2 to 7 days after 
ROSC may predict a poor neurological outcome in combination 
with other prognostic tests (Class IIb, Level B-NR).
Withdrawal of life-sustaining treatment
We suggest that withdrawal of life-sustaining treatment based 
on predicted poor neurological outcome are postponed until at 
least 72 hours after ROSC in adult comatose patients treated with 
TTM (Class IIa, Level C-LD).
Organ donation
Organ donation should be considered in comatose patients who 
fulfill neurological criteria for brain death after ROSC or cardiac 
arrest patients who have not achieved ROSC from cardiac arrest 
(Class IIb, Level C-LD).
Rehabilitation and long-term care 
We recommend structured assessment for anxiety, depression, 
post-traumatic stress, and fatigue for cardiac arrest survivors (Class 
I, Level B-NR).
 We recommend that cardiac arrest survivors have multimodal 
rehabilitation assessment and treatment for physical, neurologi-
cal, cardiopulmonary, and cognitive impairments before hospital 
discharge and receive a comprehensive, multidisciplinary discharge 
plan including medical and rehabilitative treatment (Class I, Level 
C-LD).
Cardiac arrest center
Adult patients with non-traumatic out-of-hospital cardiac arrest 
(OHCA) should be considered for transport to a hospital that can 
provide 24-hour coronary angiography and TTM (Class IIb, Level 
B-NR).
Post-cardiac ARREST CARE
In the 2020 CPR guidelines, post-cardiac arrest care is also em-
phasized as a key element in the chain of survival. The post-car-
diac arrest care algorithm presents treatment strategies and ther-
apeutic goals to be considered in the initial stabilization stage 
followed by investigation of the cause of cardiac arrest, treat-
ment of reversible causes, and intensive care strategies to reduce 
additional brain damage. In addition, continued management 
planning, such as secondary prevention and rehabilitation for 
cardiac arrest survivors, and neurological prognostication for pa-
tients who do not recover consciousness after a certain period of 
time are newly included (Fig. 1).
Airway and breathing
When a cardiac arrest patient is unconscious after ROSC, the air-
way should be secured by endotracheal intubation if endotrache-
al intubation has not been performed during CPR. There is no RCT 
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determining whether different oxygen concentrations or avoiding 
hypoxemia before measuring SpO2 or PaO2 is associated with 
clinical outcomes. However, one observational study has reported 
that hypoxemia is associated with a poor outcome. Hypoxemia is 
theoretically likely to cause tissue damage by causing tissue hy-
poxia.5 Therefore, we recommend avoiding hypoxemia in adults 
who have ROSC. In addition, to prevent further damage due to 
tissue hypoxia, we suggest to apply 100% oxygen until SpO2 or 
PaO2 can be accurately measured in adults who have ROSC. 
 Several RCTs have compared low-dose oxygen treatment with 
high-dose oxygen treatment in prehospital settings in patients 
after ROSC.6-9 While oxygen treatment at a lower concentration 
compared to 100% oxygen treatment had no benefit for survival 
discharge in a cluster RCT, targeting of oxygen concentrations 
lower than 100% showed a benefit for survival discharge.6-8 In a 
meta-analysis that evaluated survival discharge with good neu-
rological outcomes, there was no benefit of supplying low con-
centrations of oxygen.5,7 In a study comparing the target treat-
ment for normal oxygenation and the target treatment for hyper-
oxia after the intensive care unit admission, the target treatment 
for normal oxygenation had no benefit. On the other hand, in sub-
group analysis of a RCT, treatment that avoided hyperoxia had 
benefit for 90-day survival with good neurological outcome.9-11 
Although four observational studies showed that targeted treat-
Fig. 1. Algorithm for post-cardiac arrest care. ECG, electrocardiography; PCI, percutaneous coronary intervention; VF/VT, ventricular fibrillation/ventricu-
lar tachycardia; TTM, targeted temperature management; CT, computed tomography; EEG, electroencephalography.
Return of spontaneous circulation
Airway
   -  Endotracheal intubation for the patients who are unresponsive to verbal 
commands or fail to maintain an airway
Breathing
  -  Mechanical ventilation for the patients who fail to maintain optimal 
ventilation/oxygenation (goals: SpO2 94%–98%, PaCO2 35-45 mmHg
Circulation
  -  Intra-arterial blood pressure monitoring, intravenous access, infusion of fluid 
and/or vasopressors/inotropes (goal: systolic blood pressure 100 mmHg)
Initial 
stabilization
12-lead ECG
Coronary angiography
±PCI
Yes
Yes
No
No
Reversible causes 
  - Hypovolemia 
  - Hypoxia 
  - Hydrogen ion (acidosis)
  - Hypo-/hyperkalemia 
  - Hypothermia 
  - Tension pneumothorax 
  - Tamponade, cardiac 
  - Toxins 
  - Thrombosis, pulmonary 
  - Thrombosis, coronary
ST segment elevation, sustained VF/VT, 
or cardiogenic shock?
Appropriate response to the verbal 
commands?
TTM (32°C–36°C for 24 hr)
Brain CT 
EEG monitoring
Investigation for the cause,
intensive care,  
prognostication,  
and rehabilitation
Evaluate and treat reversible etiologies
  - Echocardiography 
  - Chest/abdominal CT
Intensive care 
  - Maintain mean arterial pressure >65 mmHg 
  - Hourly urine output 0.5 mL/kg 
  - Maintain normoxia and normocapnia 
  - Maintain normal range of blood glucose level 
  - Lung protective ventilation (tidal volume of 6-8 mL/kg) 
  - Early diagnosis/treatment of seizures
Neurological prognostication (see the prognostication algorithm)
Secondary prevention and expert consultation for continued management 
and rehabilitation
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ment for hyperoxia was associated with low survival rates or poor 
neurological outcomes, six studies did not show such associa-
tion.5,12-20 Therefore, we suggest avoiding hyperoxemia by titrat-
ing the fraction of inspired oxygen to target an oxygen saturation 
of 92% to 98% in patients who remain comatose after ROSC.
 Hypercapnia increases cerebral blood flow and intracranial pres-
sure, while hypocapnia reduces cerebral blood flow and intracra-
nial pressure. Two RCTs comparing two different PaCO2 targets 
have been reported. A RCT with a low LOE compared treatments 
targeting high-normal PaCO2 (44–46 mmHg) with low-normal 
PaCO2 (33–35 mmHg) after ROSC and the other RCT with a low 
LOE compared treatments targeting moderate hypercapnia (50–
55 mmHg) with normocapnia (35–45 mmHg). As a result, treat-
ment targeting high hypercapnia did not have benefits compared to 
treatment targeting normal or low-normal hypocarbia.11,21 In ob-
servational studies, it has been reported that hypercapnia shows con-
tradictory results or it is not associated with good outcome.5,12,15,22-24 
Hypocapnia has also showed similar results and no studies had 
reported its benefits. Therefore, we suggest maintaining PaCO2 
within a normal physiological range of 35–45 mmHg in adults 
who have ROSC after a cardiac arrest.
Circulation
Hemodynamic stabilization
Immediately after ROSC, arterial pressure should be continuously 
monitored by rapidly inserting an arterial catheter along with ECG 
monitoring. If the arterial catheter cannot be inserted, blood pres-
sure should be measured frequently by a non-invasive method 
until the patient is hemodynamically stabilized.
 One observational study has compared a group with a mean 
arterial pressure (MAP) of 70 to 90 mmHg and a group with a MAP 
>90 mmHg and found that the group with MAP >90 mmHg 
had better neurological outcomes.25 A RCT has compared a MAP 
of 85 to 100 mmHg target and a MAP of 65 mmHg target and 
found that cerebral oxygen saturation measured by near-infrared 
spectroscopy was higher in the group with a MAP of 85 to 100 
mmHg without showing differences in neurological outcomes 
between the two groups.26 A RCT has compared a MAP of 80 to 
100 mmHg target with a 65 to 75 mmHg target and found no 
difference in NSE or neurological outcomes at 48 hours.27 How-
ever, in both RCTs, the sample size was insufficient to determine 
the effect on survival or neurological outcomes. Thus, it is cur-
rently difficult to determine the effect of a treatment targeting 
an average MAP >65 mmHg
 Hypotension can reduce oxygen delivery to tissues by decreas-
ing perfusion to organs including the brain. Hypotension after 
ROSC (defined as systolic blood pressure <90 mmHg or MAP 
<65 mmHg) is associated with death and poor neurological out-
comes in a number of observational studies.28-34 However, the ev-
idence is insufficient to determine a specific hemodynamic goal 
for post-cardiac arrest patients. It is suggested that hypotension 
should be corrected quickly, and a hemodynamic goal should be 
determined for individual patients, while maintaining a systolic 
blood pressure >100 mmHg.
Investigation for the causes of cardiac arrest and  
treatment of reversible causes 
Intervention for acute coronary syndromes
Acute coronary syndromes are common causes of adult cardiac 
arrest.35-37 Thus, 12-lead ECG and cardiac marker tests should be 
performed as soon as possible after ROSC to confirm the pres-
ence or absence of acute coronary syndrome. It is recommended 
to perform emergency coronary angiography for all cardiac arrest 
patients with ST segment elevation on ECG after ROSC regardless 
of their state of consciousness.38
 In a large-scale RCT conducted in patients with suspected acute 
coronary syndrome among cardiogenic cardiac arrest patients 
without ST segment elevation on ECG after ROSC, after compar-
ing the strategy of performing coronary angiography within 2 
hours after ROSC and the strategy of performing coronary angi-
ography after neurological recovery, there was no difference in 
90-day mortality or neurological outcome.39 In a meta-analysis 
of 11 studies (including four RCTs), there was no difference in 30-
day mortality rate, neurological outcome, or the ratio of coronary 
intervention between the strategy of early coronary angiography 
and the strategy of post-stable coronary angiography.40 Accord-
ing to results of an additional meta-analysis, in the case of sus-
pected acute coronary syndrome among patients with cardiogen-
ic cardiac arrest and no ST segment elevation on ECG after ROSC, 
short-term mortality rates were compared between patients who 
underwent coronary angiography immediately after hospital visit 
and those who underwent coronary angiography after neurologi-
cal stabilization. Results revealed no difference in 30-day mortal-
ity between the two groups.36,41-43 In four observational studies 
comparing short-term mortality of patients who underwent coro-
nary angiography immediately after hospital visit and those who 
did not undergo coronary angiography, patients who underwent 
coronary angiography immediately after the hospital visit showed 
lower mortality than those who did not undergo coronary angi-
ography.36,43-45 In three observational studies comparing short-
term neurological outcome of patients who underwent coronary 
angiography immediately after admission to the hospital and 
those who underwent coronary angiography after neurological 
stabilization, there was no difference in short-term neurological 
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outcome between the two groups.36,42,43 In three observational 
studies, patients who underwent coronary angiography immedi-
ately after hospital visit showed a better short-term neurological 
outcome than those without coronary angiography.36,43,44 There-
fore, we suggest performing coronary angiography after neuro-
logical recovery from hospitalization rather than early coronary 
angiography for adults without ST segment elevation on ECG af-
ter ROSC when no obvious non-cardiac cause is identified. More-
over, unlike in the West, it is necessary to take into consideration 
the reality that there are many sudden cardiac deaths due to cor-
onary artery spasm in Korea. Thus, early coronary angiography 
should not be routinely performed in patients without ST segment 
elevation after ROSC when there are no indications for emergenct 
coronary angiography, including cardiogenic shock, persistent 
ventricular tachycardia or ventricular fibrillation, and persistent 
ischemic chest pain.46 Even if there is no ST segment elevation on 
ECG after ROSC, when patients are in a state of electrical insta-
bility with persistent ventricular tachycardia or ventricular fibril-
lation, severe coronary artery stenosis has been found in 85% of 
patients. Moreover, early coronary angiography should be per-
formed even in the case of cardiogenic shock because the possi-
bility of multivascular coronary artery disease and left main coro-
nary artery lesions is high.37,47,48
Treatment of pulmonary embolism
There were no RCTs about the treatment of cardiac arrest due to 
pulmonary embolism. Observational studies evaluating the effec-
tiveness of fibrinolysis treatment in patients with suspected pul-
monary embolism have found significant risk of bias with diverse 
outcomes.49-53 In two case reports, including 21 patients who un-
derwent CPR or surgical thrombectomy due to cardiac arrest with 
pulmonary embolism, 30-day survivals were 12.5% and 71.4%, 
respectively.54,55 In a case report of patients with cardiac arrest 
due to pulmonary embolism, 6 out of 7 patients treated with per-
cutaneous thrombectomy showed ROSC.56 In one RCT and several 
observational studies, the risk of major bleeding was relatively 
low in patients who underwent thrombolysis and CPR.49,51,52
 There is no robust evidence that reperfusion through removal 
of blood clots in cardiac arrest due to pulmonary embolism can 
improve the outcomes. However, the risk of death from cardiac 
arrest is greater than the risk of bleeding from thrombolysis and 
mechanical or surgical thrombectomy. Therefore, thrombolytic 
agents, mechanical or surgical thrombectomy can be considered 
as treatments for cardiac arrest due to pulmonary embolism. Since 
there are no clear benefits for either technique, the choice of treat-
ment can be determined by the time elapsed from cardiac arrest 
and the presence or absence of experts.
 The effectiveness of thrombolytic therapy in cardiac arrest pa-
tients with suspected but unclear pulmonary embolism is cur-
rently uncertain. One recent study has reported that the risk of 
major bleeding in cardiac arrest patients treated with thrombo-
lytics is not high.51 Therefore, if pulmonary embolism is strongly 
suspected in the absence of ROSC, thrombolytics can be consid-
ered.
Treatment for optimizing neurological recovery
Temperature control
Prevention and treatment of hyperpyrexia
Observational studies have reported that fever is associated with 
poor outcome in patients who have not received TTM after ROSC.57-61 
Hyperpyrexia occurs in many patients after TTM. However, the 
association of hyperpyrexia with outcome is not consistent among 
studies.62-66 Although the effect of hyperpyrexia on the outcome 
of post-cardiac arrest patients is not proven, a poor outcome was 
associated with hyperpyrexia in comatose patients in whom ce-
rebral damage was due to other causes such as cerebral hemor-
rhage or infarct. The method of preventing or treating hyperther-
mia is relatively easy to apply.67,68 Therefore, it is suggested to 
continuously prevent or treat fever in adult comatose patients 
after ROSC regardless of whether the patient received TTM. 
TTM
• Indication and optimal target temperature
One RCT and a pseudo-randomized trial demonstrated that TTM 
of 32°C to 34°C can improve neurological outcome at hospital 
discharge and at 6 months compared to no temperature control 
in adult OHCA with shockable rhythms. Therefore, OHCA with a 
shockable rhythm is a main indication for TTM.69,70
 Three small RCTs have compared TTM at 32°C to 34°C to nor-
mothermia in adult OHCA with non-shockable rhythms.71-73 
However, since the sample sizes of the studies were too small and 
the clinical outcome was not the primary end point, it was diffi-
cult to derive meaningful conclusion. A large RCT with moderate 
LOE (HYPERION trial) including 584 adult OHCA and in-hospital 
cardiac arrest (IHCA) patients has compared 33°C TTM and 37°C 
normothermia.74 The 33°C group showed a significantly better 
neurologic outcome at 90 days compared to the 37°C group.74 In 
the process of evidence review for the 2020 guidelines, results of 
the HYPERION trial and results of two small-sized randomized 
controlled studies with very low LOE were included for a meta-
analysis. Results revealed that TTM did not reduce the mortality 
rate at 90 or 180 days compared to normothermia. However, a 
meta-analysis of two studies that included neurological outcome 
at 90 or 180 days revealed that 32°C or 33°C TTM reduced the in-
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cidence of poor neurological outcomes at 90 or 180 days com-
pared to normothermia.
 On the other hand, there is no RCT for IHCA comparing TTM 
with no temperature control. In a retrospective cohort study with 
very low LOE involving 1,836 IHCA patients, TTM at 32°C to 34°C 
was not associated with survival or good neurological outcome 
compared to those without active temperature control. In a large-
scale retrospective cohort study of 26,183 IHCA registry data us-
ing propensity scores matched analysis, TTM at 32°C to 34°C was 
not associated with a good neurological outcome at survival or 
discharge.75,76 However, the TTM rate for the patients included in 
these studies was very low and the risk of bias was high due to a 
large number of missing data. Therefore, it is difficult to accept 
that the results of the studies are clinically meaningful and a RCT 
is necessary.
 There are not many RCTs comparing different target tempera-
tures. In a RCT involving 939 OHCA with cardiogenic cause of all 
rhythms except unwitnessed asystole, TTM at 33°C and 36°C was 
compared. There was no significant difference between two tem-
perature groups in 6-month mortality, poor neurologic outcome, 
or side effects. Through these results, ultra-mild hypothermia (36°C) 
emerged as another target temperature.77 Meanwhile, in a pre-
liminary RCT comparing TTM of 32°C, 33°C, and 34°C reported in 
2018, there was no significant difference in neurologic outcome 
at 90 days among these groups.78
 In the 2020 guidelines, we recommend performing TTM to main-
tain a constant target temperature between 32°C and 36°C to all 
adult cardiac arrest patients who do not respond to verbal com-
mands after ROSC regardless of the initial ECG rhythm (Class I, 
Level B-R).
• Timing to initiate and duration of TTM
Several studies have compared the prehospital induction of TTM 
with hospital induction of TTM. In all seven RCTs with a moderate 
LOE, there was no significant difference between the groups in 
mortality or poor neurologic outcome.79-85
 A meta-analysis of 7 studies also did not show differences in 
the mortality or poor neurologic outcome at hospital discharge 
between the two groups.86 In a study comparing a group of OHCA 
who were rapidly infused with cold saline during cardiac arrest 
with a group of OHCA with induced hypothermia after arriving at 
the hospital, the ROSC rate decreased significantly while acute 
pulmonary edema increased significantly in patients receiving 
cold saline infusion during cardiac arrest.87 In addition, neurologic 
outcome at 90 days was not different in a study comparing OHCA 
for whom TTM was rapidly induced by spraying a coolant into the 
nasal cavity during cardiac arrest with OHCA receiving standard-
of-care.88 There is no evidence yet that starting TTM in the pre-
hospital setting is more beneficial than starting it in a hospital. 
Therefore, further research is needed.
 There is no definitive interventional study that has determined 
the optimal duration of TTM after cardiac arrest. In a RCT com-
paring 24-hour with 48-hour TTM for OHCA, neurological out-
come at 6 months was not significantly different between the 
two groups.89 However, due to a small sample size, the efficacy of 
48-hour TTM could not be concluded. Therefore, based on the 
duration used in two largest aforementioned RCTs, it is reason-
able to maintain TTM for at least 24 hours after achieving the 
target temperature. 
• TTM methods 
Various cooling methods can be used to induce and maintain a 
target temperature, but there is no single ideal method yet. Ex-
ternal surface cooling methods (e.g., cooling blanket, ice packs, 
and a wet towel) have been used widely in the past. It has the 
advantage of being easy to use and convenient to apply. However, 
it has disadvantages in that the speed of lowering the patient’s 
core temperature is slow. In addition, it is difficult to maintain at 
a constant level, which adds to the medical staffs’ high workload. 
Recently, cooling equipment using intravascular catheters or ex-
ternal cooling equipment equipped with a precise automatic feed-
back system have become available. Thus, body temperature con-
trol has become easy, but expensive. Therefore, medical staff that 
plan to perform TTM should consider various factors (e.g., the place 
to initiate the treatment, staff’s ability and experience, speed of 
induction, stability during maintenance and rewarming, mobility of 
the equipment, adverse events associated with specific equip-
ment or techniques, convenience of using the equipment, cost, 
etc.), and the most optimal cooling method should be chosen for 
individual patients.90 
 The cold crystalloid IV fluid infusion method is relatively easy 
to use, and it was widely used as a method for inducing hypo-
thermia in prehospital settings or during resuscitation for conve-
nience. However, rapidly infusing a large amount of cold IV fluid 
during resuscitation or immediately after ROSC is no longer rec-
ommended to induce hypothermia because it can significantly 
increase the incidence of acute pulmonary edema.79,83,85,86,88
 When performing TTM, the patient’s core temperature should 
be continuously monitored in the esophagus, bladder, or pulmo-
nary artery. The pulmonary artery temperature is the most accu-
rate, but it has a limitation because it requires an invasive proce-
dure. The axillary or oral temperature is not appropriate for mea-
suring change in core temperature, and tympanic temperature 
probes are difficult to use for a long time and often inaccurate. 
S48 www.ceemjournal.org 
2020 CPR guidelines: post–cardiac arrest care
The rectal temperature is commonly used, but caution is required 
because there can be temperature gaps when hypothermia is in-
duced rapidly.91
 Moreover, there is not enough evidence for an optimal rewarm-
ing rate. Therefore, at this point, it is suggested to rewarm at a 
rate of 0.25°C to 0.5°C per hour, which has been used often in 
previous studies and maintain normothermia (36.5°C to 37.5°C) 
up to 72 hours after ROSC in comatose patients even after nor-
mothermia is achieved.
Glucose control 
In a RCT on patients treated with target blood glucose levels of 
72 to 108 mg/dL or 108 or 144 mg/dL, the 30-day mortality rate 
did not differ between the two groups.92 In a before-and-after 
study that used a bundle of care with a target blood glucose level 
of 90 to 144 mg/dL, the neurological outcome improved after 
implementing the bundle, but the effect could not be attributed 
only to the controlled blood glucose level.93 It may not be appro-
priate to use blood glucose control methods for critically ill pa-
tients based on results of studies on patients with cardiac ar-
rest.94-96 Although the blood glucose control method in critically 
ill patients remains controversial, strict control of blood glucose 
has been associated with an increased incidence of hypoglyce-
mia.92 Therefore, the target range of 144 to 180 mg/dL is sug-
gested to prevent hypoglycemia, although evidence is still insuf-
ficient. Hyperglycemia above 180 mg/dL should be treated with 
an insulin infusion according to the hospital-specific protocol 
and care should be taken to prevent hypoglycemia (<80 mg/dL). 
If hypoglycemia occurs, it should be immediately corrected by 
administering a glucose solution. 
Control of seizures 
In comatose patients after ROSC, the prevalence of seizures, non-
convulsive status epilepticus, and other similar seizures is esti-
mated to be about 20% to 30%.97 We recommend treatment of 
clinically apparent seizures to prevent a secondary brain injury in 
comatose adults after ROSC.98,99
 If seizures occur or are suspected, EEG should be performed. In 
addition, considering the high incidence of non-convulsive sei-
zures in comatose patients after ROSC, EEG should be actively 
performed if possible. There is a debate about whether the EEG 
method should be continuous EEG in terms of diagnostic utility 
and cost-effectiveness.100,101
 However, in comatose patients after ROSC, it is often difficult to 
clinically confirm whether the patient has seizures due to the use 
of sedatives or muscle relaxants during TTM. Therefore, it is newly 
recommended to monitor such patients using continuous EEG.102,103
 Rapid injections of anticonvulsants are commonly used to con-
trol seizures. Fosphenytoin, sodium valproate and levetiracetam 
are all effective in controlling seizures. However, fosphenytoin is 
associated with a high incidence of hypotension.104,105 Sedatives 
such as propofol and midazolam are also effective in suppressing 
seizure waves after a cardiac arrest.106 Continued myoclonic sta-
tus after ROSC may not respond well to anticonvulsants.107 We 
suggest that routine seizure prophylaxis should not be used in 
comatose adults after ROSC due to the lack of research to sup-
port their usage.
Sedation
Sedation therapy to reduce shivering during mechanical ventila-
tion or TTM is a routine treatment after ROSC. However, there is 
no high-quality evidence to define the duration of sedation and 
neuromuscular blockade in patients after ROSC. A meta-analysis 
of sedative drugs used during TTM in 68 intensive care units in 
various countries has revealed that a wide variety of drugs have 
been used.108 Although drugs that might be related to prognosis 
are currently unknown, it showed that a combination therapy of 
opioids and sedatives was mainly used. In addition, short-acting 
drugs such as propofol, dexmedetomidine, and remifentanil pro-
vided reliable evaluation of neurological conditions and progno-
sis. It is recommended to use sedatives with a short duration of 
action if possible. However, no analysis or treatment policy has 
been established for the effect of using sedatives after a cardiac 
arrest. A previous study has suggested that continuous adminis-
tration of neuromuscular blockers to patients undergoing post-
cardiac arrest is associated with a low mortality rate.109 However, 
administration of neuromuscular blockers can interfere with neu-
rological examination and make it impossible to detect the oc-
currence of seizures. 
Use of prophylactic antibiotics
Two RCTs and several observational studies on the use of prophy-
lactic antibiotics in post-cardiac arrest care were reviewed.110-113 
In the two RCTs, there were no significant differences in survival, 
neurological outcome, or infection incidence according to pro-
phylactic antibiotic use.110,111 In one RCT, the incidence of pneu-
monia was low in patients receiving prophylactic antibiotics. How-
ever, there was no significant difference in survival or neurologi-
cal outcome between patients receiving prophylactic antibiotics 
and those who did not receive such antibiotics. Therefore, the 
benefit of the routine use of prophylactic antibiotics in patients 
with ROSC is uncertain.111
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Evaluation of neurological prognostication
Accurate neurological prognostication is important to prevent in-
appropriate withdrawal of life-sustaining treatment in patients 
who still have a chance to have potentially meaningful neurolog-
ical recovery and to avoid futile treatment in patients with a se-
vere and irreversible neurological injury. However, until now, no 
single test can completely predict prognosis of the comatose pa-
tient after ROSC. Thus, it is necessary to integrate the results of 
multiple tests to prognosticate. In addition, since the process of 
predicting neurological prognostication may be affected by drugs 
(sedatives and neuromuscular blockers) and TTM, it should be 
conducted under conditions that minimize the confounding ef-
fects. The 2020 guidelines recommend an approach to perform 
the neurological prognostication process as follows (Fig. 2). 1) We 
recommend that neurological prognostication for comatose pa-
tients after ROSC should proceed after a sufficient time has elapsed 
to minimize confounding effects and errors during the recovery 
period. 2) Even though the individual test may be performed ear-
lier, we suggest using the multimodal approach at a minimum of 
72 hours after normothermia (5 days after ROSC). 3) The neuro-
logical prognostication in an adult comatose patient after ROSC 
should not be performed by only one test result. It should use a 
multimodal approach using the results of various tests such as 
clinical examination, electrophysiology, biomarkers, and imaging. 
 Poor neurological outcome could be suspected if at least two 
findings are observed among the following six test results. If not, 
Fig. 2. Algorithm for prognostication after cardiac arrest. CT, computed tomography; NSE, neuron specific enolase; SSEP, somatosensory evoked potential; DW-
MRI, diffusion weighted-magnetic resonance imaging; aEEG, amplitude-integrated electroencephalography; EEG, electroencephalography; TTM, targeted tem-
perature management; ROSC, return of spontaneous circulation. 
At least two or more of the following ? 
  -  Reduction of the gray-white matter ratio on brain CT or  
Extensive restriction on brain DW-MRI at 2 to 7 days
  -  Bilaterally absent N20 SSEP wave at >24 hr
  -  Burst suppression on EEG at >72 hr or   
No normal trace on aEEG monitoring ≤36 hr
  -  High NSE level at 24-72 hr
  -  Status myoclonus ≤72 hr
  -  No pupillary and corneal reflexes at ≥72 hr
  Recommended timing of prognostic tests
Status myoclonus
Serum NSE
SSEP N20 
DW-MRI 
Continuous EEG or aEEG monitoring, EEG test
Pupillary reflex, corneal reflex,
pupillometry
At least 72 hr after normothermia (25 days after ROSC) 
Exclude confounders (esp. residual sedation or paralysis)
Coma and motor response 1-3
Observe and re-evaluate
Observe and re-evaluate
Br
ai
n 
CT
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
            
                 TTM and controlled normothermia
No
No
Yes
Yes
Poor neurological outcome likely
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the prognosis should be determined by comprehensively judging 
various findings after further observation and reevaluation. 
 1) Reduction of the GWR on brain CT or extensive restriction 
on brain diffusion-weighted magnetic resonance imaging includ-
ing ADC at 2 to 7 days; 2) bilaterally absent N20 waves in SSEP 
test at >24 hours; 3) burst suppression occurring on EEG at >72 
hours or no normal trace on amplitude-integrated EEG monitor-
ing ≤36 hours; 4) high level of serum NSE at 24 to 72 hours; 5) 
observation of status myoclonus ≤72 hours; and 6) loss of both 
pupillary light and corneal reflexes at ≥72 hours.
Clinical examination
Bilateral absent pupillary light reflexes or corneal reflexes, and 
quantitative pupillometry in patients who remain comatose at 72 
hours or later after ROSC may predict a poor neurological out-
come in combination with other prognostic tests.102,114-135 Auto-
mated pupillometry provides an objective and quantifiable mea-
surement of the pupillary response. The most common quantita-
tive pupillometry measures, percentage of reduction of pupil size 
and neurological pupil index, can be used to predict neurological 
outcome at 72 hours after ROSC.123,126,136-138
 On the other hand, myoclonus and status myoclonus observed 
within 72 hours after ROSC may predict a poor neurological out-
come. However, it is recommended to evaluate them in combina-
tion with other prognostic tests.102,119,127,129,131,139-143 EEG record-
ings may also be considered in case of status myoclonus to find 
related epileptic activity.
Electrophysiology
SSEP
In 21 studies, when bilateral absence of N20 waves was observed 
in the SSEP conducted at 24 hours or more after ROSC, a poor 
neurological outcome was predicted with specificity of 50% to 
100% and sensitivity of 18.2% to 70.5%.101,102,114,121,123,127,128,134,144-
156 Although decrease in the amplitude of N20 is associated with 
a poor neurological outcome in some studies, further studies are 
needed.152,155,157,158 Since there is a high likelihood that results are 
affected by confounding factors within 24 hours after ROSC, it is 
recommended to use bilateral absence of N20 waves more than 
24 hours after ROSC in combination with other prognostic tests.
EEG
• Seizures recorded on EEG
In five studies, seizures recorded on EEG within 120 hours after 
cardiac arrest predicted poor neurological outcome with specific-
ity of 100% and sensitivity of 0.6% to 26.8%.139,159-162 As seizures 
recorded on EEG show a low sensitivity for predicting poor neu-
rological outcome, some patients with seizures can recover with 
a good outcome. Thus, the usefulness of seizures recorded on EEG 
as a prognostic predictor is currently unclear.
• Burst suppression
In seven studies, burst suppression appearing within 120 hours 
after ROSC predicted poor neurological outcome with specificity 
of 90.7% to 100% and sensitivity of 1.1% to 47%.131,139,144,147,161,163,164 
The definition of burst suppression was not consistent for each 
study and the recording time also varied. In addition, effects of 
drugs cannot be excluded. Therefore, each study does not show a 
high LOE. Burst suppression on EEG after sedation has been 
weaned off at 72 hours or more after ROSC may predict a poor 
neurological outcome in combination with other prognostic tests.
• Epileptiform discharges
Epileptiform discharges can be divided into two types: rhythmic/
periodic discharge and sporadic, non-rhythmic/periodic discharge. 
In 11 studies, rhythmic/periodic discharges predicted a poor neu-
rological outcome with specificity of 66.7% to 100% and sensi-
tivity of 2.4% to 42.9% if they appeared within 120 hours after 
ROSC.102,120,127,151,153,159-161,163,165,166 In 5 studies, sporadic, non-rhyth-
mic/periodic discharges predicted poor neurological outcome with 
specificity of 66.7% to 100% and sensitivity of 0.4% to 38.5% if 
they appeared within 120 hours after ROSC.120,147,151,159,160 The 
variable definition of epileptiform discharges between studies, 
the effects of sedative drugs, and the variable background EEG 
make epileptiform discharges unreliable predictors. Therefore, it is 
recommended not to use epileptiform discharges as a predictor 
of poor neurological outcome in comatose patients after ROSC.
• EEG unreactivity
In 15 studies, when EEG unreactivity within 72 hours after ROSC 
was present, a poor neurological outcome was predicted with spec-
ificity of 41.7% to 100% and sensitivity of 50% to 97.1%.102,119,127, 
131,145,148,150,160,162,167-172 In addition, stimulation and response were 
not consistently defined for each study. The effect of drugs was 
not taken into account either. Thus, it is not recommended to use 
EEG unreactivity in comatose patients after ROSC as a predictor 
of poor neurological outcome.
Continuous amplitude-integrated EEG
In comatose patients treated with TTM, the absence of a normal 
trace within 36 hours after ROSC in amplitude-integrated EEG 
monitoring may predict a poor neurological outcome in combina-
tion with other prognostic tests.173-175
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Biological marker
In comatose patients treated with TTM, high serum levels of NSE 
measured at 24 to 72 hours after ROSC may predict a poor neu-
rological outcome in combination with other prognostic tests. How-
ever, a cut-off value for predicting a poor neurological outcome 
with a 0% false-positive rate cannot be clearly recommended.115, 
121,124,127,131,135,176-180 It is suggested not to use S-100B protein to 
predict neurological outcomes in comatose adults after ROSC. It 
is also suggested not to use serum glial fibrillary acidic protein, 
serum tau protein, or serum neurofilament protein to predict poor 
neurological outcomes in comatose adults after ROSC.181-187
Neuroimaging
The degree of cerebral edema identified as a reduced GWR on 
brain CT in comatose patients after ROSC, extensive areas of re-
stricted diffusion in brain MRI, and a reduced ADC can be used to 
predict poor neurological outcome. 
  In brain CT, the GWR of a specific area was evaluated (mostly 
within 24 hours after ROSC) and its specificity for a poor neuro-
logical outcome was reported to be 85% to 100%.116,134,135,176,188-194 
However, the specific threshold of the possible GWR and the 
most appropriate timing of brain CT scan remain unknown.
 If diffusion restriction was observed on MRI performed within 
5 days after ROSC, the specificity for poor neurological outcome 
was reported to be 55.7% to 100%.117,132,134 There have been stud-
ies trying to predict poor neurological outcome with ADC values 
of MRI performed within 7 days after ROSC.195-197 Quantitative 
ADC measurements are promising. However, the specific thresh-
old of ADC for predicting poor neurological outcome is unknown 
due to the availability and diversity of measurement methods.
 In comatose patients after ROSC, if used in combination with 
other predictors, remarkably reduced GWR on brain CT taken with-
in 24 hours after ROSC or extensive areas of restricted diffusion 
with ADC reduction in brain MRI taken at 2 to 7 days after ROSC 
is recommended as a predictor.
Withdrawal of life-sustaining treatment
The Well-Dying Act was enforced in February 2018 in Korea. The 
Act has legally allowed to withdraw life-sustaining care, resulting 
in a major change in post-cardiac arrest care. Two observational 
studies with very low LOE showed that early withdrawal of life-
sustaining treatment within 72 hours after ROSC was associated 
with increased mortality or poor neurological function at hospital 
discharge.198,199 Therefore, we suggest that withdrawal of life-
sustaining treatment based on predicted poor neurologic out-
come be postponed until at least 72 hours after ROSC in adult co-
matose patients treated with TTM.
Organ donation 
Transplantation-related studies cannot be conducted prospec-
tively. Therefore, it can be said that results of large retrospective 
studies have similar impact to those of prospective studies. In ad-
dition, complications after transplantation are different in each 
organ. The quality of donated organs does not depend on wheth-
er or not CPR has been performed, but functional warm ischemic 
time and no perfusion time might play more important roles. Af-
ter reviewing several retrospective studies, transplantation out-
comes of organs donated from donors who died due to failure to 
achieve ROSC in recent studies were found to be acceptable. It 
has been reported that transplantation outcomes of donors who 
died due to brain death after ROSC are not bad compared to 
those of donors who have not undergone CPR.200-209 Based on the 
results of published studies so far, it has been summarized that 
CPR does not affect outcomes of the transplanted organ.210 
Therefore, organ donation should be considered in comatose pa-
tients who ]fulfill neurological criteria for brain death after ROSC 
or cardiac arrest patients who have failed to ROSC from cardiac 
arrest.
 Among patients who have ROSC after CPR, one can be presumed 
to be brain death if following conditions are met 1) no spontane-
ous breathing and breathing is maintained with a ventilator; 2) 
cause of arrest is certain and an irreversible brain injury is proven; 
3) absence of more than 5 of 7 brainstem reflexes; and 4) no spe-
cific causes of arrest such as carbon monoxide poisoning, meta-
bolic disorders, or suicide attempts which require medical obser-
vation. We recommend that medical staff who treat a patient 
who has suspected brain death should report the suspected brain 
death for organ donation.211
 When notifying a suspected brain death after CPR, medical 
staff should confirm the state of the suspected brain death and 
the explanation of the suspected brain death notification system 
to the guardian to confirm the consent for organ donation. Prior 
to evaluation for organ donation, the degree of awareness of the 
guardian about the presumed brain death condition and donor 
family information should be confirmed. Confirmation of donor 
family information includes confirmation of consent for organ 
donation, relationship and contact information with the donor, 
and confirmation of priority guardians.211
Rehabilitation and long-term care 
Assessment and early rehabilitation after post-cardiac 
arrest
Cardiac arrest survivors experience a variety of physical, cognitive, 
and psychological problems, like other critically ill patients.212 Psy-
chological disorders such as anxiety, depression, and post-trau-
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matic stress in particular are experienced by about a third of pa-
tients revived from a cardiac arrest. Fatigue is also often accom-
panied by other disorders.212-215 Families of cardiac arrest patients 
also experience severe stress and psychological problems.216-220 
These psychological problems have a significant effect on the long-
term prognosis and quality of life of cardiac arrest patients.216-220 
However, there are many cases where adequate treatment can-
not be provided because it is not always recognized by the medi-
cal staff.221-223 Therefore, we recommend structured assessment 
for anxiety, depression, post-traumatic stress, and fatigue for car-
diac arrest survivors so that psychological problems that are com-
mon to survivors after a cardiac arrest can be identified without 
missing them and appropriate treatment can be provided to them 
to improve their long-term prognosis. 
 Cognitive impairments such as memory, attention, and execu-
tive function are commonly observed in cardiac arrest survivors. 
It is associated with a lower quality of life.224-229 After intensive 
care, muscle weakness, gait impairment, dysphagia, and cardio-
pulmonary impairment are also common.230 Therefore, we recom-
mend that cardiac arrest survivors have multimodal rehabilitation 
assessment and treatment for physical, neurological, cardiopul-
monary, and cognitive impairments before hospital discharge. Cur-
rently, studies on the effects of rehabilitative evaluation and 
treatment after cardiac arrest are insufficient. However, consider-
ing the effects of early rehabilitation for critically ill patients and 
rehabilitation effects on physical and cognitive impairment in 
stroke and traumatic brain injury, the effects of rehabilitation in-
terventions after cardiac arrest are also expected and thus further 
studies are needed.230-236
Discharge plan and long-term care after discharge
Various medical problems and disabilities that occur after cardiac 
arrest can cause difficulties in returning to society and work.226,237-239 
In addition, there is a need for patients and caregivers to provide 
appropriate information about the patient’s condition.217,240-242 
Therefore, comprehensive and multidisciplinary discharge plan-
ning, including medical and rehabilitation medical treatment plans, 
should be established for cardiac arrest survivors. 
 Three RCTs have demonstrated the effects of long-term care 
on improvement of long-term outcomes in cardiac arrest survi-
vors. In one study, early, individualized, semi-structured interven-
tions were performed for symptoms of neurological injury to the 
survivors in the experimental group and a significant improve-
ment in emotional, mental health, and general health items of 
SF-36 was observed in the experimental group compared to the con-
trol group.243 In the experimental group, overall emotional state 
and anxiety assessed by the HADS (Hospital Anxiety and Depres-
sion Scale) were significantly improved. There was no significant 
difference in the degree of social participation between the two 
groups at 1 year. However, the return-to-work rate at 3 months 
was significantly higher in the experimental group.
 In a cost-effectiveness analysis using the same study data, the 
overall cost did not differ significantly between the group with 
interventions focusing on early neurological symptoms and the 
control group. For the incremental cost effectiveness ratio, the 
intervention was found to be cost-effective.244 In a RCT of 133 
OHCA survivors, relaxation, self-management, and coping strate-
gies were assisted in the experimental group. The psychosocial 
treatments consisting of cognitive behavioral therapy to reduce 
depression and anxiety and education on cardiovascular risk fac-
tors were provided twice a week for a total of 11 treatments for 
the experimental group and compared with the conventional 
treatment group. At 2 years, the risk of cardiovascular death rate 
was significantly reduced in the experimental group.245 
 In one study, structured information was provided to a randomly 
assigned experimental group of 168 patients with implantable 
defibrillators after cardiac arrest or fatal arrhythmia. Phone coun-
seling was conducted once a week (15 to 20 minutes per session) 
for a total of 8 weeks.246 Telephone counseling was conducted for 
the purpose of assisting in the recovery process after implanta-
tion of an implantable defibrillator, enhancing self-efficacy, and 
relieving emotional stress and anxiety. At 6 and 12 months, phys-
ical and psychological adaptation, self-efficacy, and medical use 
were evaluated. As a result, physical concern, anxiety, and fear of 
death were significantly reduced in the experimental group. Self-
efficacy and knowledge of implantable defibrillator management 
was also significantly improved in the experimental group. In a 
recent interventional observational study without a control group, 
a multidisciplinary, structured psychological, cognitive, and medi-
cally supported care program that could be provided from hospi-
tal discharge to 12 months after discharge was developed and 
applied for cardiac arrest survivors.247 The program structure con-
sists of a wide range of cognitive and psychological evaluations 
during hospitalization, provision of various types of information, 
telephone consultation on the 2nd day after discharge, multidis-
ciplinary evaluation and consultation for about 1 hour through 
an outpatient visit at 8, 6, and 12 months after discharge, and so 
on. The above care treatment program was applied to 19 cardiac 
arrest survivors. Results confirmed that the quality of life evalu-
ated by SF-36 was improved in almost all areas at 6 months com-
pared to the time of discharge. Therefore, it is recommended to 
consider the provision of individualized long-term care taking the 
problems such as cognitive impairment, anxiety, and depression 
of cardiac arrest survivors into account.
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Cardiac arrest center
It is well known that transfer of patients to hospitals where com-
prehensive post-cardiac arrest care can be performed efficiently 
after cardiac arrest was associated with survival and good neuro-
logical outcomes.248-264 A meta-analysis of 17 observational stud-
ies revealed that patients treated at the cardiac arrest center 
showed higher survival and neurologically favorable survival dis-
charge rates compared to those treated at the other hospitals. 
However, there was no significant difference in 30-day mortality 
or neurological outcomes between the two groups.265 The reason 
was that there was no clear definition of cardiac arrest centers 
and there was no large RCT. In many studies, the availability of 
24-hour coronary angiography, TTM, and neurointensive care are 
included in the definition of a cardiac arrest center. In fact, since 
ischemic heart disease is the main cause of sudden cardiac arrest, 
we also suggest that 24-hour coronary angiography and TTM are 
included in the definition of the centers when defining cardiac 
arrest centers in Korea.266
 We suggest that adult patients with non-traumatic OHCA should 
be considered for transport to a hospital that can provide 24-hour 
coronary angiography and TTM. It is reasonable to transfer to a 
cardiac arrest center where coronary angiography is possible. If 
an OHCA patient visits a hospital where coronary angiography is 
not possible, it may be effective to immediately transfer the pa-
tient to a hospital at a level where coronary angiography is possi-
ble. However, considering the domestic reality that only 20% of 
patients with acute myocardial infarction use emergency medical 
systems and about half of patients with ST segment elevation 
acute myocardial infarction visit hospitals where coronary angi-
ography is not possible at the first visit, clear guidelines for transfer 
of cardiac arrest patients is needed along with a public an-
nouncement.267 In addition, since the concept of a cardiac arrest 
center has not been established in Korea, it is necessary to discuss 
the concept of the function, level and designation of cardiac ar-
rest centers in our emergency medical system.
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